| Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours. | |
| | |
MedLine Citation:
|
PMID: 18811055 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Normal proliferating cells and tumour cells in particular express the pyruvate kinase isoenzyme type M2 (M2-PK, PKM2). The quaternary structure of M2-PK determines whether the glucose carbons are degraded to pyruvate and lactate with production of energy (tetrameric form) or channelled into synthetic processes, debranching from glycolytic intermediates such as nucleic acid, amino acid and phospholipid synthesis. The tetramer:dimer ratio of M2-PK is regulated by metabolic intermediates, such as fructose 1,6-P2 and direct interaction with different oncoproteins, such as pp60v-src kinase, HPV-16 E7 and A-Raf. The metabolic function of the interaction between M2-PK and the HERC1 oncoprotein remains unknown. Thus, M2-PK is a meeting point for different oncogenes and metabolism. In tumour cells, the dimeric form of M2-PK is predominant and has therefore been termed Tumour M2-PK. Tumour M2-PK is released from tumours into the blood and from gastrointestinal tumours also into the stool of tumour patients. The quantification of Tumour M2-PK in EDTA plasma and stool is a tool for early detection of tumours and therapy control. |
| | |
Authors:
|
S Mazurek |
Related Documents
:
|
22250975 - Effect of uv-a irradiance on lipid accumulation in nannochloropsis oculata. 6774935 - Isolation, characterization and biological activities of verotetrone from a mutant stra... 8298275 - The role of polyamines in fungal cell differentiation. 3826495 - Alkylphosphonates as unique compounds in the metabolism of the schistosomal vector biom... 22577495 - Human umbilical mesenchymal stem cell and its adipogenic differentiation: profiling by ... 11725785 - Development of a microgravity-compatible reagentless organic acid and alcohol monitor (... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Ernst Schering Foundation symposium proceedings Volume: - ISSN: - ISO Abbreviation: Ernst Schering Found Symp Proc Publication Date: 2007 |
Date Detail:
|
Created Date: 2008-09-24 Completed Date: 2008-11-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101312605 Medline TA: Ernst Schering Found Symp Proc Country: Germany |
Other Details:
|
Languages: eng Pagination: 99-124 Citation Subset: IM |
Affiliation:
|
ScheBo Biotech AG, Netanyastrasse 3, 35394 Giessen, Germany. s.mazurek@schebo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Glycolysis Humans Isoenzymes / metabolism Metabolism Models, Biological Neoplasm Proteins / metabolism Neoplasms / enzymology* Protein Interaction Mapping Pyruvate Kinase / metabolism* Tumor Markers, Biological / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Isoenzymes; 0/Neoplasm Proteins; 0/Tumor Markers, Biological; EC 2.7.1.40/Pyruvate Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biomarker discovery for drug development and translational medicine using metabonomics.
Next Document: Molecular imaging of tumor metabolism and apoptosis.